Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03591744
Brief Title: Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia

First Submitted : July 9, 2018
First Submitted that Met QC Criteria : July 9, 2018
First Posted : July 19, 2018

Last Update Submitted that Met QC Criteria : December 17, 2018
Last Update Posted : December 19, 2018